Consumer-driven healthcare (CDH) has become pervasive over the last decade as a powerful tool to help address the cost crisis in the American healthcare system. The success of CDH in reversing the cost trend – together with the recent rise in health savings account (HSA) adoption – confirms that CDH will continue to thrive into the future.
Despite its success, CDH, as we know it today, is far from perfect. Employers struggle to effectively design a CDH program (the combination of the health plan
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Canadian Government Awards $49M Grant to Establish Canada-wide AI Health Data Platform
The government of Canada has announced an investment grant of up to $49 million in the Digital Health and Discovery Platform (DHDP), a network of partners that seeks to establish a cutting-edge Canada-wide health data platform. Through this new platform, researchers and doctors will work to accelerate the development of new and personalized treatments to help to find cures for diseases that affect Canadians. While the platform will initially focus on cancer, the plan is to expand to other areas
Read More
Healthcare M&A: Agfa to Consider Selling Health IT & Integrated Care Business
Last week Agfa announced its Board of Directors would investigate the sale of part of Agfa HealthCare, specifically, the business tied to its EMR and integrated care offerings. The facts are:· In March 2019, Agfa initially stated that it would further extend the independence of Agfa HealthCare.· It has now expanded on what this could potentially look like, stating it will explore selling is Hospital IT and Integrated Care solutions.· In terms of its reportable business this is largely the
Read More
Stanford Spinout Cardinal Analytx Lands $22M for AI-Enabled Health Insights
Cardinal Analytx Solutions, an artificial intelligence (AI)-enabled health insights company has raised $22 million in Series B funding round led by John Doerr including participation from GuideWell Mutual Holding Corporation, Blue Shield California and Premera Blue Cross.Getting Ahead of High Cost EventsHealth insurers, accountable healthcare providers and other health industry stakeholders recognize that U.S. health care spending growth and shortfalls in treatment outcomes are not sustainable.
Read More
Alegeus Unveils Smart HSA Solution to Bolster Healthcare Spending and Saving Decisions
Alegeus, the market leader in consumer-directed healthcare (CDH) solutions, today announced that the industry’s first Smart HSA that features machine learning and artificial intelligence (AI) was presented for the first time during the 2019 Alegeus Client Conference. Smart HSA: A New Approach to CDH Account SolutionsThis next generation of the existing Alegeus solution provides broader support for the benefits lifecycle and greater influence across the full spectrum of healthcare benefits. It
Read More
Zebra Medical Vision Granted FDA 510k Clearance for AI Chest X-Ray Triage
Zebra Medical Vision, an Israli-based deep learning imaging analytics company, today announces that it has received FDA 510(k) clearance for HealthPNX – an AI-powered alert for pneumothorax (PNX), based on chest X-rays.FDA 510(k) Clearance DetailsReceived in May 2019, the FDA 510(k) clearance focuses on an AI alert for “stat” (urgent) findings of pneumothorax and demonstrates a promising potential to substantially reduce turnaround time and increase the radiologist’s confidence in making this
Read More
Clinical Operations Makes Highest Use of Artificial Intelligence, Tufts Study Finds
Clinical operations function makes the highest use of artificial intelligence (AI) (61%), followed by pharmacovigilance/safety/risk management (57%), and information technology (IT) (55%), according to an analysis recently completed by the Tufts Center for the Study of Drug Development. The analysis, summarized in the May/June Tufts CSDD Impact Report, reveals the pharmaceutical industry is adopting artificial intelligence (AI) on numerous fronts, from discovery and clinical development to risk
Read More
UCSF, The Doctors Company Partner to Address Patient Safety Challenges in the Digital Health Era
The Doctors Company—the nation’s largest physician-owned medical malpractice insurer—and UC San Francisco (UCSF), today launched a new partnership at the intersection of digital medicine and patient safety. The Doctors Company’s commitment to advancing the practice of good medicine will be expanded through a $1 million collaboration that will enable leading UCSF researchers in evidence-based patient safety practices, safety, and information technology–related policy, and artificial intelligence
Read More
Analysis: 5 Trends Shaping The Future of The Global Radiology IT Market
Against the backdrop of artificial intelligence in medical imaging and other hyped healthcare IT technologies, market trends in core radiology IT software and services can easily be overlooked. Many of the largest markets in North America and Western Europe have reached saturation, with few new “greenfield” opportunities. Instead, the dynamics of much of the global radiology IT market revolve around long procurement cycles, replacement or contract roll-on and an entrenched customer base.However,
Read More
FDA Grants Breakthrough Designation to RenalytixAI for AI-Enabled Diagnostic for Kidney Disease
RenalytixAI, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, today announced that it has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA), for its lead diagnostic, KidneyIntelX™. This is the first such designation for an AI-enabled diagnostic for kidney disease publicly announced by any company.FDA Breakthrough Devices Program OverviewThe FDA’s Breakthrough Devices Program is a voluntary program for certain
Read More
